Which hepatitis B serologic markers should be ordered after a suspected exposure?

Hepatitis B Serological Testing After Suspected Exposure

After a suspected hepatitis B exposure, order HBsAg, total anti-HBc, and anti-HBs immediately to determine the source patient's infection status and the exposed person's immune status. 1

Initial Testing Panel for the Exposed Person

The three-marker panel provides complete information to guide post-exposure prophylaxis decisions:

• HBsAg identifies active infection (acute or chronic) in the exposed person, which would contraindicate HBIG and alter management 1
• Total anti-HBc distinguishes natural immunity from vaccine-induced immunity and identifies past exposure 1, 2
• Anti-HBs determines protective immunity status; levels ≥10 mIU/mL indicate protection and eliminate the need for post-exposure prophylaxis regardless of source status 1

Source Patient Testing

Test the source patient for HBsAg immediately to determine if post-exposure prophylaxis is needed. 1 Testing should occur simultaneously with exposed person testing and should not be delayed. 1

Post-Exposure Prophylaxis Decision Algorithm

If Exposed Person Has Anti-HBs ≥10 mIU/mL:

• No post-exposure prophylaxis needed, regardless of source HBsAg status 1
• This applies to both vaccine responders and those with natural immunity 1

If Exposed Person Has Anti-HBs <10 mIU/mL and Source is HBsAg-Positive:

For unvaccinated or incompletely vaccinated persons:

• Administer HBIG (0.06 mL/kg IM) as soon as possible, preferably within 24 hours (effectiveness unknown if given >7 days after percutaneous exposure or >14 days after sexual exposure) 1
• Simultaneously administer first dose of hepatitis B vaccine at a separate anatomic site 1
• Complete the 3-dose vaccine series on schedule 1

For previously vaccinated persons with documented complete series:

• Administer 1 dose of HBIG and 1 dose of hepatitis B vaccine as soon as possible 1
• Complete a second vaccine series (total 6 doses when counting original series) 1
• Test anti-HBs 1-2 months after final dose to document response status 1

For vaccine non-responders (anti-HBs <10 mIU/mL after two complete series):

• Administer 2 doses of HBIG: first dose immediately, second dose 1 month later 1
• Additional vaccine doses are not recommended 1
• Test for HBsAg and anti-HBc to confirm the person is not chronically infected 1

If Source is HBsAg-Negative or Unknown:

For persons with anti-HBs <10 mIU/mL:

• Administer a single booster dose of hepatitis B vaccine 1
• Retest anti-HBs 1-2 months later 1

Follow-Up Testing for Exposed Persons

If the source is HBsAg-positive or unknown and the exposed person received post-exposure prophylaxis:

• Baseline testing immediately after exposure: total anti-HBc 1
• Follow-up at 6 months: HBsAg and total anti-HBc 1
• This identifies potential HBV transmission despite prophylaxis 1

Critical Timing Considerations

The effectiveness of post-exposure prophylaxis is time-dependent:

• Percutaneous exposures: Initiate within 24 hours; unlikely to be effective if >7 days 1
• Sexual exposures: Initiate within 24 hours; unlikely to be effective if >14 days 1
• Perinatal exposures: Administer HBIG and vaccine at delivery 1

Common Pitfalls to Avoid

• Do not delay testing the source patient while waiting for exposed person's results, and vice versa 1
• Do not assume protection in persons who received childhood vaccination without documented anti-HBs testing, as antibody levels wane over time 1
• Do not test for anti-HBs in unvaccinated persons to guide post-exposure management, as the correlate of protection (≥10 mIU/mL) only applies to completed vaccine series 1
• Do not withhold HBIG while waiting for serologic results if the source is known to be HBsAg-positive and the exposed person's immune status is unknown 1
• Do not test discarded needles or syringes for virus contamination when the source is unknown 1

Special Populations

Healthcare personnel: Should have documented anti-HBs testing 1-2 months after completing vaccination series to establish baseline immune status and guide post-exposure management 1

Pregnant women: Post-exposure prophylaxis should not be withheld; exposed persons do not need to modify sexual practices or delay pregnancy during follow-up 1